Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 54:
55. The compound of claim 49, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2 is phenyl, wherein the phenyl is substituted by 1, 2, 3, 4, or 5 independently selected R2d substituents;
at least one R2d is 5- or 6-membered heteroaryl, wherein the 5- or 6-membered heteroaryl is optionally substituted by 1, 2, 3, 4, or 5 independently selected R4a substituents; and
each R4a is independently 0-5 C1-C6 alkyl.